Topic: Exploring 3' UTR-Mediated Membrane Protein Trafficking for Cancer Immunotherapy
Abstract: Depleting RNA helicase DDX3 reduces cell surface PD-L1 and increases T cell infiltration into mouse oral tumors, leading to our investigation of its mechanism and evaluation its anti-cancer potential. We demonstrated that DDX3 recruits the adaptor protein 2 (AP2) complex to the 3’ UTR of PD-L1 mRNA, thereby facilitating membrane trafficking of newly synthesized PD-L1. Inhibition of DDX3 or disruption of its interaction with AP2 markedly impaired cell-surface expression of PD-L1. To further dissect this 3’ UTR-dependent trafficking mechanism and identify potential inhibitors, we recently conducted a drug screen. Notably, compounds that disrupt lipid rafts substantially reduced surface PD-L1 levels. Inhibition of cholesterol biosynthesis diminished PD-L1 partitioning into lipid rafts and impaired its transport from the Golgi apparatus to the plasma membrane. Both DDX3 and the 3’ UTR of CD274 were required for this trafficking pathway. In addition to CD274, DDX3 bound mRNAs encoding multiple raft-associated proteins and promoted both their localization to lipid rafts and the surface expression of their encoded proteins. Notably, many DDX3 target transcripts contained RNA G-quadruplex (rG4) structures. Stabilization of rG4 structures dissociated DDX3 from its target mRNAs and consequently blocked surface expression of the encoded proteins. Collectively, these findings support a model in which DDX3 loads nascent cargo proteins onto endoplasmic reticulum raft microdomains through a 3’ UTR-dependent mechanism, thereby accelerating their trafficking to the plasma membrane. Importantly, in combination with anti-CTLA4 therapy, pharmacological inhibition of raft trafficking significantly enhanced anticancer immunotherapeutic efficacy.
Time: 2026.6.23 (Tuesday) 10:30 am
Venue: Lecture Room C212, Building C, National Biotechnology Research Park
Speaker: Dr. Woan-Yuh Tarn
Distinguished Research Fellow, Institute of Biomedical Sciences
Host: Dr. Chien-Chang Chen
Director, Biomedical Translation Research Center
Organizer: Biomedical Translation Research Center, Academia Sinica
Registration: https://forms.gle/KLxbRkQUxjJcHJ3W9
